Kidney Involvement in Systemic Calcitonin Amyloidosis Associated With Medullary Thyroid Carcinoma

Humphreys, 2005, Renal failure associated with cancer and its treatment: an update, J Am Soc Nephrol, 16, 151, 10.1681/ASN.2004100843 Ronco, 1999, Paraneoplastic glomerulopathies: new insights into an old entity, Kidney Int, 56, 3553, 10.1046/j.1523-1755.1999.00548.x Sipe, 2014, Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis, Amyloid, 21, 221, 10.3109/13506129.2014.964858 Eisenberg, 2012, The amyloid state of proteins in human diseases, Cell, 148, 1188, 10.1016/j.cell.2012.02.022 Bellotti, 2007, The workings of the amyloid diseases, Ann Med, 39, 200, 10.1080/07853890701206887 Fogo, 2015, AJKD atlas of renal pathology: AL amyloidosis, Am J Kidney Dis, 66, e43, 10.1053/j.ajkd.2015.10.006 Kumar, 2005 Westermark, 2012, Localized AL amyloidosis: a suicidal neoplasm?, Ups J Med Sci, 117, 244, 10.3109/03009734.2012.654861 Matias-Guiu, 2014, Medullary thyroid carcinoma: a 25-year perspective, Endocr Pathol, 25, 21, 10.1007/s12022-013-9287-2 Erickson, 2015, Analysis of amyloid in medullary thyroid carcinoma by mass spectrometry-based proteomic analysis, Endocr Pathol, 26, 291, 10.1007/s12022-015-9390-7 Westermark, 2011, Amyloid diagnosis, subcutaneous adipose tissue, immunohistochemistry and mass spectrometry, Amyloid, 18, 175, 10.3109/13506129.2011.631270 Costante, 2009, Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls, Nat Clin Pract Endocrinol Metab, 5, 35, 10.1038/ncpendmet1023 Reches, 2002, Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin, J Biol Chem, 277, 35475, 10.1074/jbc.M206039200 Sletten, 1976, Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid, J Exp Med, 143, 993, 10.1084/jem.143.4.993 Arvinte, 1993, The structure and mechanism of formation of human calcitonin fibrils, J Biol Chem, 268, 6415, 10.1016/S0021-9258(18)53268-3